Skip to content

Long-Term Longitudinal QoL in Patients Undergoing EEA

A Prospective Longitudinal Quality of Life Study in Patients Undergoing Endoscopic Endonasal Skull Base Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04087902
Enrollment
400
Registered
2019-09-12
Start date
2019-07-16
Completion date
2027-12-31
Last updated
2026-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chondrosarcoma, Chordoma, Craniopharyngioma, Encephalocele, Esthesioneuroblastoma, Meningioma, Pituitary Tumor, Rathke Cleft Cysts

Keywords

Endoscopic Endonasal Approach Surgery

Brief summary

This is a prospective longitudinal study to access postoperative 2-year quality of life in patients who undergo endonasal endoscopic approach surgeries of the skull base.

Detailed description

This is a prospective single-institution longitudinal study to access quality of life in patients who undergo endonasal endoscopic approach surgeries of the skull base. Patients will be followed before surgery and up to twenty-four months post-surgery. The primary goal of the study is to assess the alterations to patient quality of life following endoscopic endonasal surgery using modern sinonasal reconstruction techniques. Secondary goals are to better understand the time course of normal healing and patient/procedural risk factors associated with poorer quality of life outcomes.

Interventions

None listed

Sponsors

Ohio State University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Patient is scheduled to undergo endoscopic endonasal surgery. Multiple, staged surgeries are not exclusionary * 18 years of age or older * The subject must in the investigator's opinion, be psychosocially, mentally, and physically able to fully comply with this protocol including the required follow-up visits, the filling out of required forms, and have the ability to understand and give written informed consent

Exclusion criteria

* Patient is a prisoner * Patient is not English speaking * Patient is not expected to survive until the 2-year follow-up

Design outcomes

Primary

MeasureTime frameDescription
PROMIS-29 quality of life outcome measures for patients undergoing endoscopic endonasal surgeries.24-months post-operativelyThis study aims to better understand the long-term overall quality of life of patients undergoing endoscopic endonasal surgery using modern sinonasal reconstruction techniques. The PROMIS-29 metric, an overall quality of life metric, will be used to better understand quality of life for patients undergoing this procedure.

Secondary

MeasureTime frameDescription
ASK Nasal-12 questionnaire used to measure normal time of healing for patients undergoing endoscopic endonasal surgery24 months post-operativelyThis study aims to better understand the overall nose function in patients undergoing endoscopic endonasal surgery using modern sinonasal techniques. The ASK Nasal-12 metric is designed to evaluate nose overall nose function such as post-nasal drip, ability to smell, and pain.
Number of patients with long-term quality of life risk factors using PROMIS-2924 months post-operativelyThis study aims to better understand the number of long-term risk factors for patients undergoing endoscopic endonasal surgeries using modern sinonasal reconstruction techniques. This will be done using the PROMIS-29 metric along with patient data.
Number of patients with long-term procedural comorbidities using ASK-Nasal 12.24 months post-operativelyThis study aims to better understand the number of long-term comorbidities for patients undergoing endonasal endoscopic surgeries using modern sinonasal reconstruction techniques. This will be done using the ASK-Nasal 12 metric along with patient data.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORKyle Wu, MD

Ohio State University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 21, 2026